258 related articles for article (PubMed ID: 35677506)
1. Value of Liver Function Tests in Cirrhosis.
Sharma P
J Clin Exp Hepatol; 2022; 12(3):948-964. PubMed ID: 35677506
[TBL] [Abstract][Full Text] [Related]
2. (
Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive biomarkers of Fontan-associated liver disease.
Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
[TBL] [Abstract][Full Text] [Related]
4. Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF.
Fossdal G; Mjelle AB; Wiencke K; Bjørk I; Gilja OH; Folseraas T; Karlsen TH; Rosenberg W; Giil LM; Vesterhus M
JHEP Rep; 2021 Oct; 3(5):100328. PubMed ID: 34485881
[TBL] [Abstract][Full Text] [Related]
5. Overview of Complications in Cirrhosis.
Premkumar M; Anand AC
J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
[TBL] [Abstract][Full Text] [Related]
6. Correlation of baseline Portal pressure (hepatic venous pressure gradient) and Indocyanine Green Clearance Test With Post-transarterial Chemoembolization Acute Hepatic Failure.
Khisti R; Patidar Y; Garg L; Mukund A; Thomas SS; Sarin SK
J Clin Exp Hepatol; 2019; 9(4):447-452. PubMed ID: 31516260
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
Arora A; Sharma P
J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of hepatic reserve function of cirrhosis liver using dynamic SPECT (99m)Tc-galactosyl human serum albumin scintigraphy].
Xiang CH; Chen YM; Shao MZ; Li C; Liu HS; Zhang JM; Liu ZW; Duan WD; Cai SW; Tian JH; Dong JH
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):592-5. PubMed ID: 24256582
[TBL] [Abstract][Full Text] [Related]
11. Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading.
Wei L; Ye Z; Bao Z; Xu X; Lin X; Chen L
Clinics (Sao Paulo); 2020; 75():e1670. PubMed ID: 32935822
[TBL] [Abstract][Full Text] [Related]
12. Short-term prognostic factors for primary sclerosing cholangitis.
Watanabe T; Hirano K; Tada M; Isayama H; Mizuno S; Arizumi T; Toda N; Sugawara Y; Kokudo N; Koike K
J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):486-90. PubMed ID: 25826613
[TBL] [Abstract][Full Text] [Related]
13. Embedding assessment of liver fibrosis into routine diabetic review in primary care.
Mansour D; Grapes A; Herscovitz M; Cassidy P; Vernazza J; Broad A; Anstee QM; McPherson S
JHEP Rep; 2021 Aug; 3(4):100293. PubMed ID: 34179738
[TBL] [Abstract][Full Text] [Related]
14. Acoustic radiation force impulse elastography: comparison and combination with other noninvasive tests for the diagnosis of compensated liver cirrhosis.
Pfeifer L; Adler W; Zopf S; Siebler J; Wildner D; Goertz RS; Schellhaas B; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 May; 29(5):524-530. PubMed ID: 28067683
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes.
Tica S; Alghamdi S; Tait C; Nemera B; Turmelle Y; Fleckenstein J; Stoll J; Kulkarni S
J Clin Exp Hepatol; 2022; 12(1):110-117. PubMed ID: 35068791
[TBL] [Abstract][Full Text] [Related]
16. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
[TBL] [Abstract][Full Text] [Related]
17. A Study on FibroScan and Endoscopic Finding in Patients of Chronic Liver Disease attending Tripura Medical College and Dr. B.R. Ambedkar Memorial Teaching Hospital.
Debnath G; Chakraborty A
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702844
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
19. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
20. The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.
Kumar PA; Subramanian K
J Clin Diagn Res; 2016 Mar; 10(3):BC09-12. PubMed ID: 27134856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
